Quantcast

Latest Off-label use Stories

2013-07-05 23:00:52

Parker Waichman LLP is concerned that the public has not been properly educated about the clinically proven potential side effects that could result from Medtronic’s Infuse bone graft product. At the same time, the product continues to be used in ways for which it wasn’t approved, which only heightens the risks of side effects for patients undergoing these procedures. New York, New York (PRWEB) July 05, 2013 Parker Waichman LLP, a national law firm dedicated to protecting the rights...

2013-06-21 23:01:55

Johnson & Johnson is appealing the $1.2 billion fine issued by an Arkansas court over off-label marketing claims the company supposedly made regarding its antipsychotic drug Risperdal. However, a large number of Arkansas lawmakers are supporting the fine, and Parker Waichman LLP applauds their efforts as it continues to offer free legal advice to patients who took Risperdal, which has been associated with side effects such as male breast enlargement (gynecomastia). New York, NY (PRWEB)...

2013-04-17 16:49:13

Review finds little difference between effectiveness of drugs routinely prescribed for migraine prevention but evident difference in the side-effects experienced Migraine headaches are a major cause of ill health and a reduced quality of life. Some individuals suffer from a frequent and severe migraine problem which means that they require regular medication to try and prevent them. A new review´ of the medications, which may help to prevent episodic migraines, appears in the Journal...

2012-11-06 03:51:36

Special issue honors Frances O. Kelsey, pioneer in drug safety and regulation Pharmaceutical health services research goes beyond studying the effects of individual drugs, to looking at the complex and interrelated effects of medications on the health of patients and the population. The special November issue of Medical Care highlights important new papers in key areas of pharmaceutical health services research. The journal is published by Lippincott Williams & Wilkins, a part of...

2012-10-22 22:15:37

"Off label" drugs are medications that have not been tested for safety or efficacy for a specific patient age or condition. New research presented Oct. 21 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans found that off-label treatments were ordered for 96 percent of all pediatric patients, and 100 percent of patients ages 13-17, in the intensive care unit of an urban children's hospital. In "Off-Label Drug Use in the Pediatric Intensive Care...

2012-10-09 04:00:39

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates aspire to provide the public with free online information regarding the potential dangers of using certain prescription medications, has a Web site URL located at http://www.depakotebirthinjury.com. The CJF hereby alerts the public that a federal judge in Virginia has accepted the terms of the settlement between the Department of Justice and Abbott Laboratories regarding the allegedly...

2012-08-08 22:19:28

Conflict-of-interest statements made by physicians and scientists in their medical journal articles after they had been allegedly paid by pharmaceutical manufacturers as part of off-label marketing programs are often inadequate, highlighting the deficiencies in relying on author candidness and the weaknesses in some journal practices in ensuring proper disclosure, according to a study by international researchers published in this week's PLOS Medicine. Off-label marketing is the promotion by...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'